News

Tamiflu, which is indicated for the prevention and treatment of influenza types A and B in patients one year and older, is currently available in a 75mg capsule

By step-wise dose escalation, a safe dose of 1mg/day of TASQ was achieved, which corresponds to a doubling of the previously reported maximum tolerated dose level of 0.5mg/day.

SCOLR Pharma had previously announced a research collaboration with an undisclosed US-based biopharmaceutical company in September 2006. Peramivir is being developed by BioCryst and is part of a

The Stanford work raises the possibility that humans could make use of this immune response if their immune system compromised. The evidence shows that a fruit fly’s immune

The research examined 20 studies on the effects of statins that covered 828 patients. Of those studies, 291 patients were given statins, 272 were given a placebo and

There are two major strains of malaria effecting humans, P. vivax and P. falciparum. Although attention focuses on the more virulent P. falciparum, vivax malaria causes a huge

A court previously ruled that Abbott was prohibited from any further sales, use or export of products, including components that infringe on Innogenetics’ patent on its hepatitis C

Basilea plans to sell up to 1.15 million new shares, one new share for each five existing shares held. The company said it had an option to offer

Teva said shipment of the cabergoline tablets, which have been cleared for 0.5mg strength, will begin immediately. Total annual sales of this product in the US, including brand